Association of serum soluble Receptor for Advanced Glycation End-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS)

OBJECTIVE: Serum levels of the soluble Receptor for Advanced Glycation End-products (sRAGE) have been associated with risk of cardiovascular disease. We hypothesized that sRAGE levels are associated with subclinical cerebrovascular disease in an ethnically diverse population. METHODS: Clinically str...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hudson, Barry I, Moon, Yeseon Park, Kalea, Anastasia Z, Khatri, Minesh, Marquez, Chensy, Schmidt, Ann Marie, Paik, Myunghee C, Yoshita, Mitsuhiro, Sacco, Ralph L, DeCarli, Charles, Wright, Clinton B, Elkind, Mitchell SV
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3089661/
https://ncbi.nlm.nih.gov/pubmed/21316677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2011.01.024
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados